This MedLibrary.org supplementary page on Dacryocystitis is provided directly from the open source Wikipedia as a service to our readers. Please see the note below on authorship of this content, as well as the Wikipedia usage guidelines. To search for other content from our encyclopedia supplement, please use the form below:
Related Sponsors
| Dacryocystitis Classification and external resources |
|
| ICD-10 | H04.3-H04.4 |
|---|---|
| ICD-9 | 375.30 |
| DiseasesDB | 3432 |
| eMedicine | oph/708 |
| MeSH | D003607 |
Dacryocystitis is an infection of the nasolacrimal sac. It causes pain, redness and swelling over the inner aspect of the lower eyelid and epiphora. It is often caused by nasolacrimal obstruction. It is commonly associated with Staphylococcus aureus, Streptococcus pneumoniae, Pseudomonas species.
Clinical features
- pain, swelling, redness over the lacrimal sac at medial canthus.
- tearing, crusting, fever
- digital pressure over the lacrimal sac may extrude pus through the punctum
- In chronic cases, tearing may be the only symptom
Treatment
- warm compresses, nasal decongestants, systemic and topic antibiotics
- if chronic, obtain cultures by aspiration
- Once infection resolves consider Dacryocystorhinostomy(DCR)
External links
 |
This disease article is a stub. You can help Wikipedia by expanding it. |
Wikipedia content modification information:
- This page was last modified on 10 August 2008, at 05:49.
Wikipedia Authorship and Review
Wikipedia content provided here is not reviewed directly by MedLibrary.org. Wikipedia content is authored by an open community of volunteers and is not produced by or in any way affiliated with MedLibrary.org.
Wikipedia Usage Guidelines
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article on "Dacryocystitis".
The URL for this specific entry is:
All Wikipedia text is available under the terms of the GNU Free Documentation License. (See Copyrights for details). Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc.